In their research, the scientists developed a process for creating the experimental vaccine by focusing on two key proteins that help form the virus — both H5 and N1. The process was called a ...

A vaccine under development at UB has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work, detailed in a study published April 17 in the ...

Researchers at the University of Hong Kong said on Thursday they have discovered two methods which can help develop a ...

The contract covers more than 5 million doses of a CSL Seqirus H5 influenza shot, according to a government statement, which said the vaccines would be manufactured by the company's UK subsidiary.

A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work, detailed in a study ...

BUFFALO, N.Y. — A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work, detailed in ...

Lovell and colleagues tested the vaccine platform in mice with 2.3.4.4b. They used doses containing H5 alone, N1 alone, and H5 and N1 combined. They found that: H5 alone provided complete ...

H5 and N1 together, which is a bivalent vaccine, also provided complete protection, but it did not outperform H5 alone. Put another way, adding N1 did not offer more protection than H5 alone.